Ensign Peak Advisors’s Sangamo Therapeutics SGMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-31,480
| Closed | -$154K | – | 2154 |
|
|
2022
Q3 | $154K | Buy |
31,480
+26,890
| +586% | +$132K | ﹤0.01% | 1966 |
|
|
2022
Q2 | $19K | Hold |
4,590
| – | – | ﹤0.01% | 2131 |
|
|
2022
Q1 | $27K | Hold |
4,590
| – | – | ﹤0.01% | 2163 |
|
|
2021
Q4 | $34K | Buy |
+4,590
| New | +$34K | ﹤0.01% | 2162 |
|
|
2020
Q3 | – | Sell |
-6,658
| Closed | -$60K | – | 1761 |
|
|
2020
Q2 | $60K | Hold |
6,658
| – | – | ﹤0.01% | 1656 |
|
|
2020
Q1 | $42K | Sell |
6,658
-7,658
| -53% | -$48.3K | ﹤0.01% | 1608 |
|
|
2019
Q4 | $119K | Buy |
+14,316
| New | +$119K | ﹤0.01% | 1642 |
|